Total Payments
$7,833
2024 Payments
$1,174
Companies
22
Transactions
289
Payment Breakdown by Category
Food & Beverage$7,722 (98.6%)
Education$111.49 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,722 | 288 | 98.6% |
| Education | $111.49 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,740 | 52 | $0 (2024) |
| Lundbeck LLC | $1,727 | 113 | $0 (2024) |
| ABBVIE INC. | $1,102 | 38 | $0 (2024) |
| Alkermes, Inc. | $468.81 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $445.15 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $373.30 | 18 | $0 (2024) |
| Axsome Therapeutics, Inc. | $312.44 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $295.65 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $243.03 | 2 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $154.07 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,174 | 42 | E.R. Squibb & Sons, L.L.C. ($243.03) |
| 2023 | $1,503 | 44 | Teva Pharmaceuticals USA, Inc. ($302.65) |
| 2022 | $1,164 | 37 | ABBVIE INC. ($487.89) |
| 2021 | $720.71 | 42 | Lundbeck LLC ($404.71) |
| 2020 | $401.32 | 25 | Lundbeck LLC ($206.51) |
| 2019 | $1,085 | 39 | Otsuka America Pharmaceutical, Inc. ($521.25) |
| 2018 | $813.51 | 30 | Otsuka America Pharmaceutical, Inc. ($292.97) |
| 2017 | $972.32 | 30 | Otsuka America Pharmaceutical, Inc. ($553.26) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $123.06 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $119.97 | General |
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $26.07 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 06/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Central Nervous System | ||||||
| 06/11/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $14.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/10/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Andres Huberman, MD
Dr. Andres Huberman, MD is a Addiction Psychiatry healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063579043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andres Huberman, MD has received a total of $7,833 in payments from pharmaceutical and medical device companies, with $1,174 received in 2024. These payments were reported across 289 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($7,722).
Ad
Practice Information
- Specialty Addiction Psychiatry
- Location Great Neck, NY
- Active Since 01/02/2007
- Last Updated 03/27/2025
- Taxonomy Code 2084P0802X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063579043
Products in Payments
- REXULTI (Drug) $2,086
- ABILIFY MAINTENA (Drug) $1,290
- VRAYLAR (Drug) $1,227
- TRINTELLIX (Drug) $391.30
- Auvelity (Drug) $312.44
- INGREZZA (Drug) $295.65
- Aristada 441 mg (Drug) $258.65
- UZEDY (Drug) $249.99
- CAPLYTA (Drug) $153.31
- SUBLOCADE (Drug) $144.99
- Azstarys (Drug) $137.36
- SPRAVATO (Drug) $129.33
- COBENFY (Drug) $123.06
- ARISTADA (Drug) $120.00
- ABILIFY ASIMTUFII (Drug) $97.39
- Qelbree (Drug) $87.81
- Vivitrol 380 mg (Drug) $78.48
- Austedo XR (Drug) $66.55
- BELSOMRA (Drug) $66.55
- QELBREE (Drug) $66.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.